352 related articles for article (PubMed ID: 11558682)
1. Pathophysiological significance and clinical application of ANP and BNP in patients with heart failure.
Yoshimura M; Yasue H; Ogawa H
Can J Physiol Pharmacol; 2001 Aug; 79(8):730-5. PubMed ID: 11558682
[TBL] [Abstract][Full Text] [Related]
2. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
[TBL] [Abstract][Full Text] [Related]
3. Natriuretic peptides and their therapeutic potential.
Cho Y; Somer BG; Amatya A
Heart Dis; 1999; 1(5):305-28. PubMed ID: 11720638
[TBL] [Abstract][Full Text] [Related]
4. The role of natriuretic peptides in cardioprotection.
Nishikimi T; Maeda N; Matsuoka H
Cardiovasc Res; 2006 Feb; 69(2):318-28. PubMed ID: 16289003
[TBL] [Abstract][Full Text] [Related]
5. Atrial natriuretic peptides in heart failure: pathophysiological significance, diagnostic and prognostic value.
Ghosh N; Haddad H
Can J Physiol Pharmacol; 2011 Aug; 89(8):587-91. PubMed ID: 21806511
[TBL] [Abstract][Full Text] [Related]
6. [The role of natriuretic peptides in heart failure].
Ancona R; Limongelli G; Pacileo G; Miele T; Rea A; Roselli T; Masarone D; Messina S; Palmieri R; Golia E; Iacomino M; Gala S; Calabrò P; Di Salvo G; Calabrò R
Minerva Med; 2007 Oct; 98(5):591-602. PubMed ID: 18043566
[TBL] [Abstract][Full Text] [Related]
7. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.
Mukoyama M; Nakao K; Hosoda K; Suga S; Saito Y; Ogawa Y; Shirakami G; Jougasaki M; Obata K; Yasue H
J Clin Invest; 1991 Apr; 87(4):1402-12. PubMed ID: 1849149
[TBL] [Abstract][Full Text] [Related]
8. [Atrial and B-type natriuretic peptides: from the research lab to clinical practice].
Boomsma F; van den Meiracker AH
Ned Tijdschr Geneeskd; 2003 Apr; 147(16):743-8. PubMed ID: 12731463
[TBL] [Abstract][Full Text] [Related]
9. [Conditions of secretion and peripheral effects of atrial natriuretic peptide in heart failure].
Riegger AJ
Z Kardiol; 1988; 77 Suppl 5():77-86. PubMed ID: 2975895
[TBL] [Abstract][Full Text] [Related]
10. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
[TBL] [Abstract][Full Text] [Related]
11. Natriuretic peptides: biochemistry, physiology, and therapeutic role in heart failure.
Stoupakis G; Klapholz M
Heart Dis; 2003; 5(3):215-23. PubMed ID: 12783635
[TBL] [Abstract][Full Text] [Related]
12. Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure, renal failure and cancer?
Vesely DL
Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):169-76. PubMed ID: 16487258
[TBL] [Abstract][Full Text] [Related]
13. [Brain natriuretic peptide].
Tsutamoto T; Horie M
Rinsho Byori; 2004 Aug; 52(8):655-68. PubMed ID: 15478621
[TBL] [Abstract][Full Text] [Related]
14. Natriuretic peptides in relation to the cardiac innervation and conduction system.
Hansson M
Microsc Res Tech; 2002 Sep; 58(5):378-86. PubMed ID: 12226807
[TBL] [Abstract][Full Text] [Related]
15. Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in heart failure.
Bentzen H; Pedersen RS; Pedersen HB; Nyvad O; Pedersen EB
Clin Sci (Lond); 2003 Mar; 104(3):303-12. PubMed ID: 12605591
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of cardiac troponin T in patients with both acute and chronic stable congestive heart failure: comparison with atrial natriuretic peptide, brain natriuretic peptide and plasma norepinephrine.
Bertinchant JP; Combes N; Polge A; Fabbro-Peray P; Raczka F; Beck L; Cade S; Ledermann B
Clin Chim Acta; 2005 Feb; 352(1-2):143-53. PubMed ID: 15653109
[TBL] [Abstract][Full Text] [Related]
17. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
[TBL] [Abstract][Full Text] [Related]
18. Practical implications of current natriuretic peptide research.
Sagnella GA
J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):304-15. PubMed ID: 11967816
[TBL] [Abstract][Full Text] [Related]
19. Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in chronic renal failure.
Pedersen EB; Bacevicius E; Bech JN; Solling K; Pedersen HB
Clin Sci (Lond); 2006 Apr; 110(4):491-501. PubMed ID: 16396628
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of beta-human ANP.
Sugawara A; Nakao K; Morii N; Yamada T; Itoh H; Shiono S; Saito Y; Mukoyama M; Arai H; Nishimura K
J Clin Invest; 1988 Jun; 81(6):1962-70. PubMed ID: 2968368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
